share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Officer Colvin Richard A

SEC announcement ·  Mar 5 17:45
Summary by Moomoo AI
Richard A. Colvin, Chief Medical Officer of bluebird bio, Inc., completed a sale of 6,770 shares of common stock on March 1, 2024. The transaction was carried out in the open market with the shares sold at a price of $1.5276 each, resulting in a total sale value of $10,341.85. Following the sale, Colvin's direct holdings in the company amount to 118,368 shares of common stock.
Richard A. Colvin, Chief Medical Officer of bluebird bio, Inc., completed a sale of 6,770 shares of common stock on March 1, 2024. The transaction was carried out in the open market with the shares sold at a price of $1.5276 each, resulting in a total sale value of $10,341.85. Following the sale, Colvin's direct holdings in the company amount to 118,368 shares of common stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more